Abiopharma

🔍 Saggar Rajeev (Executive)

Company: Liquidia Corp (LQDA)

Report Date: 2025-08-28

Detailed Transactions and Holdings:

• Sold 20,000 shares of Common Stock at $27.8536 per share (Direct)
  Date: 2025-08-28 | Code: S | equity_swap_involved: 0 | shares_owned_after: 249,727.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 29, 2025.
• F2: Price is the volume weighted average price of all transactions made by the Reporting Person on the transaction date for prices ranging from $27.22 to $28.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: Includes (i) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 7,131 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.